STOCK TITAN

[8-K] SharpLink Gaming Ltd. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

SunLink Health Systems, Inc. (NYSE American: SSY) filed an 8-K (Item 8.01) dated 24 Jul 2025 reporting the release of a press announcement tied to its pending merger with Regional Health Properties, Inc.

  • Record date: 20 Jun 2025; shareholders are urged to submit proxy votes no later than 28 Jun 2025, 11:59 p.m. EDT.
  • Regional has already filed a Form S-4 containing the joint proxy statement/prospectus, mailed on or about 30 Jun 2025.
  • The press release is furnished as Exhibit 99.1; an Inline XBRL cover file is provided as Exhibit 104.
  • The filing reiterates that it is not an offer to sell securities and directs investors to obtain free copies of the proxy materials via the SEC or company websites.

The remainder of the report consists of forward-looking-statement disclaimers outlining risks such as potential litigation, integration hurdles, listing-requirement compliance, and macroeconomic headwinds. No financial statements or operating results are included.

SunLink Health Systems, Inc. (NYSE American: SSY) ha presentato un 8-K (Voce 8.01) datato 24 luglio 2025, comunicando il rilascio di un annuncio stampa relativo alla sua fusione in corso con Regional Health Properties, Inc.

  • Data di registrazione: 20 giugno 2025; gli azionisti sono invitati a inviare i propri voti per delega entro e non oltre il 28 giugno 2025, ore 23:59 EDT.
  • Regional ha già presentato un Modulo S-4 contenente la dichiarazione congiunta per delega/prospetto, spedito intorno al 30 giugno 2025.
  • Il comunicato stampa è fornito come Allegato 99.1; un file di copertura Inline XBRL è disponibile come Allegato 104.
  • La comunicazione ribadisce che non si tratta di un'offerta di vendita di titoli e invita gli investitori a ottenere copie gratuite dei materiali per delega tramite i siti web della SEC o della società.

Il resto del rapporto è costituito da disclaimer sulle dichiarazioni previsionali che evidenziano rischi quali possibili contenziosi, difficoltà di integrazione, conformità ai requisiti di quotazione e condizioni macroeconomiche avverse. Non sono inclusi bilanci né risultati operativi.

SunLink Health Systems, Inc. (NYSE American: SSY) presentó un 8-K (Artículo 8.01) fechado el 24 de julio de 2025, informando sobre la publicación de un comunicado de prensa relacionado con su fusión pendiente con Regional Health Properties, Inc.

  • Fecha de registro: 20 de junio de 2025; se insta a los accionistas a enviar sus votos por poder a más tardar el 28 de junio de 2025, 11:59 p.m. EDT.
  • Regional ya ha presentado un Formulario S-4 que contiene la declaración conjunta para poderes/prospecto, enviado alrededor del 30 de junio de 2025.
  • El comunicado de prensa se presenta como Exhibición 99.1; un archivo de portada Inline XBRL se proporciona como Exhibición 104.
  • La presentación reitera que no es una oferta para vender valores y dirige a los inversores a obtener copias gratuitas de los materiales de poder a través de los sitios web de la SEC o de la empresa.

El resto del informe consiste en disclaimers sobre declaraciones prospectivas que describen riesgos tales como posibles litigios, dificultades de integración, cumplimiento de requisitos de listado y vientos macroeconómicos adversos. No se incluyen estados financieros ni resultados operativos.

SunLink Health Systems, Inc. (NYSE American: SSY)는 2025년 7월 24일자 8-K (항목 8.01)를 제출하여 Regional Health Properties, Inc.와의 진행 중인 합병과 관련된 보도자료 발표를 보고했습니다.

  • 기록일: 2025년 6월 20일; 주주들은 늦어도 2025년 6월 28일 오후 11:59 EDT까지 대리 투표를 제출할 것을 권고받았습니다.
  • Regional은 이미 공동 위임장/설명서가 포함된 Form S-4를 제출했으며, 이는 2025년 6월 30일경 우편 발송되었습니다.
  • 보도자료는 Exhibit 99.1로 제공되며, 인라인 XBRL 커버 파일은 Exhibit 104로 제공됩니다.
  • 해당 제출 서류는 증권 판매 제안이 아님을 재차 명시하며, 투자자들에게 SEC 또는 회사 웹사이트를 통해 위임장 자료를 무료로 받을 것을 안내합니다.

보고서의 나머지 부분은 잠재적 소송, 통합 문제, 상장 요건 준수, 거시경제 역풍 등 위험을 설명하는 미래 예측 진술 면책 조항으로 구성되어 있습니다. 재무제표나 운영 결과는 포함되어 있지 않습니다.

SunLink Health Systems, Inc. (NYSE American : SSY) a déposé un 8-K (Article 8.01) daté du 24 juillet 2025, annonçant la publication d'un communiqué de presse lié à sa fusion en attente avec Regional Health Properties, Inc.

  • Date d'enregistrement : 20 juin 2025 ; les actionnaires sont invités à soumettre leurs votes par procuration au plus tard le 28 juin 2025, 23h59 EDT.
  • Regional a déjà déposé un Formulaire S-4 contenant la déclaration de procuration/prospectus conjoint, envoyé vers le 30 juin 2025.
  • Le communiqué de presse est fourni en tant que Pièce 99.1 ; un fichier de couverture Inline XBRL est fourni en pièce 104.
  • Le dépôt réitère qu'il ne s'agit pas d'une offre de vente de titres et invite les investisseurs à obtenir gratuitement les documents de procuration via les sites web de la SEC ou de la société.

Le reste du rapport comprend des clauses de non-responsabilité relatives aux déclarations prospectives, exposant des risques tels que des litiges potentiels, des difficultés d'intégration, la conformité aux exigences de cotation et des vents contraires macroéconomiques. Aucun état financier ni résultat opérationnel n'est inclus.

SunLink Health Systems, Inc. (NYSE American: SSY) reichte am 24. Juli 2025 ein 8-K (Punkt 8.01) ein, in dem die Veröffentlichung einer Pressemitteilung im Zusammenhang mit der anhängigen Fusion mit Regional Health Properties, Inc. gemeldet wurde.

  • Stichtag: 20. Juni 2025; Aktionäre werden aufgefordert, ihre Stimmrechtsvollmachten spätestens bis zum 28. Juni 2025, 23:59 Uhr EDT einzureichen.
  • Regional hat bereits ein Formular S-4 eingereicht, das die gemeinsame Vollmachts-/Prospekterklärung enthält, die etwa am 30. Juni 2025 versandt wurde.
  • Die Pressemitteilung ist als Anlage 99.1 beigefügt; eine Inline-XBRL-Coverdatei ist als Anlage 104 verfügbar.
  • Die Einreichung betont, dass es sich nicht um ein Angebot zum Verkauf von Wertpapieren handelt und verweist Investoren darauf, kostenlose Kopien der Vollmachtsunterlagen über die SEC- oder Unternehmenswebsites zu beziehen.

Der Rest des Berichts besteht aus Haftungsausschlüssen zu zukunftsgerichteten Aussagen, die Risiken wie mögliche Rechtsstreitigkeiten, Integrationsprobleme, Einhaltung von Börsenzulassungsanforderungen und makroökonomische Gegenwinde darlegen. Es sind keine Finanzberichte oder Betriebsergebnisse enthalten.

Positive
  • Shareholder vote scheduled for 28 Jun 2025 demonstrates the merger process is advancing on a defined timetable.
  • Form S-4 and joint proxy statement have already been mailed, showing regulatory filings are substantially complete.
Negative
  • Extensive risk disclosures emphasise litigation, integration, and listing-compliance uncertainties that could derail or delay the merger.
  • No new financial or synergy metrics were provided, leaving investors without updated economic justification for the deal.

Insights

TL;DR: Procedural 8-K: merger timetable intact; shareholder vote on 28 Jun 2025 remains key hurdle amid stated legal and integration risks.

The filing is chiefly administrative, serving to remind SunLink investors to cast their proxies on the Regional Health combination. Distribution of the Form S-4 and joint proxy statement indicates regulatory progress, but completion still depends on majority approvals and satisfaction of NYSE American and OTCQB listing standards. The expansive risk section—litigation exposure, integration complexity, revenue synergies, and macro factors—highlights substantial execution uncertainty. With no new valuation data or revised terms, the disclosure is neutral for deal odds but signals management’s commitment to move the transaction forward on schedule.

SunLink Health Systems, Inc. (NYSE American: SSY) ha presentato un 8-K (Voce 8.01) datato 24 luglio 2025, comunicando il rilascio di un annuncio stampa relativo alla sua fusione in corso con Regional Health Properties, Inc.

  • Data di registrazione: 20 giugno 2025; gli azionisti sono invitati a inviare i propri voti per delega entro e non oltre il 28 giugno 2025, ore 23:59 EDT.
  • Regional ha già presentato un Modulo S-4 contenente la dichiarazione congiunta per delega/prospetto, spedito intorno al 30 giugno 2025.
  • Il comunicato stampa è fornito come Allegato 99.1; un file di copertura Inline XBRL è disponibile come Allegato 104.
  • La comunicazione ribadisce che non si tratta di un'offerta di vendita di titoli e invita gli investitori a ottenere copie gratuite dei materiali per delega tramite i siti web della SEC o della società.

Il resto del rapporto è costituito da disclaimer sulle dichiarazioni previsionali che evidenziano rischi quali possibili contenziosi, difficoltà di integrazione, conformità ai requisiti di quotazione e condizioni macroeconomiche avverse. Non sono inclusi bilanci né risultati operativi.

SunLink Health Systems, Inc. (NYSE American: SSY) presentó un 8-K (Artículo 8.01) fechado el 24 de julio de 2025, informando sobre la publicación de un comunicado de prensa relacionado con su fusión pendiente con Regional Health Properties, Inc.

  • Fecha de registro: 20 de junio de 2025; se insta a los accionistas a enviar sus votos por poder a más tardar el 28 de junio de 2025, 11:59 p.m. EDT.
  • Regional ya ha presentado un Formulario S-4 que contiene la declaración conjunta para poderes/prospecto, enviado alrededor del 30 de junio de 2025.
  • El comunicado de prensa se presenta como Exhibición 99.1; un archivo de portada Inline XBRL se proporciona como Exhibición 104.
  • La presentación reitera que no es una oferta para vender valores y dirige a los inversores a obtener copias gratuitas de los materiales de poder a través de los sitios web de la SEC o de la empresa.

El resto del informe consiste en disclaimers sobre declaraciones prospectivas que describen riesgos tales como posibles litigios, dificultades de integración, cumplimiento de requisitos de listado y vientos macroeconómicos adversos. No se incluyen estados financieros ni resultados operativos.

SunLink Health Systems, Inc. (NYSE American: SSY)는 2025년 7월 24일자 8-K (항목 8.01)를 제출하여 Regional Health Properties, Inc.와의 진행 중인 합병과 관련된 보도자료 발표를 보고했습니다.

  • 기록일: 2025년 6월 20일; 주주들은 늦어도 2025년 6월 28일 오후 11:59 EDT까지 대리 투표를 제출할 것을 권고받았습니다.
  • Regional은 이미 공동 위임장/설명서가 포함된 Form S-4를 제출했으며, 이는 2025년 6월 30일경 우편 발송되었습니다.
  • 보도자료는 Exhibit 99.1로 제공되며, 인라인 XBRL 커버 파일은 Exhibit 104로 제공됩니다.
  • 해당 제출 서류는 증권 판매 제안이 아님을 재차 명시하며, 투자자들에게 SEC 또는 회사 웹사이트를 통해 위임장 자료를 무료로 받을 것을 안내합니다.

보고서의 나머지 부분은 잠재적 소송, 통합 문제, 상장 요건 준수, 거시경제 역풍 등 위험을 설명하는 미래 예측 진술 면책 조항으로 구성되어 있습니다. 재무제표나 운영 결과는 포함되어 있지 않습니다.

SunLink Health Systems, Inc. (NYSE American : SSY) a déposé un 8-K (Article 8.01) daté du 24 juillet 2025, annonçant la publication d'un communiqué de presse lié à sa fusion en attente avec Regional Health Properties, Inc.

  • Date d'enregistrement : 20 juin 2025 ; les actionnaires sont invités à soumettre leurs votes par procuration au plus tard le 28 juin 2025, 23h59 EDT.
  • Regional a déjà déposé un Formulaire S-4 contenant la déclaration de procuration/prospectus conjoint, envoyé vers le 30 juin 2025.
  • Le communiqué de presse est fourni en tant que Pièce 99.1 ; un fichier de couverture Inline XBRL est fourni en pièce 104.
  • Le dépôt réitère qu'il ne s'agit pas d'une offre de vente de titres et invite les investisseurs à obtenir gratuitement les documents de procuration via les sites web de la SEC ou de la société.

Le reste du rapport comprend des clauses de non-responsabilité relatives aux déclarations prospectives, exposant des risques tels que des litiges potentiels, des difficultés d'intégration, la conformité aux exigences de cotation et des vents contraires macroéconomiques. Aucun état financier ni résultat opérationnel n'est inclus.

SunLink Health Systems, Inc. (NYSE American: SSY) reichte am 24. Juli 2025 ein 8-K (Punkt 8.01) ein, in dem die Veröffentlichung einer Pressemitteilung im Zusammenhang mit der anhängigen Fusion mit Regional Health Properties, Inc. gemeldet wurde.

  • Stichtag: 20. Juni 2025; Aktionäre werden aufgefordert, ihre Stimmrechtsvollmachten spätestens bis zum 28. Juni 2025, 23:59 Uhr EDT einzureichen.
  • Regional hat bereits ein Formular S-4 eingereicht, das die gemeinsame Vollmachts-/Prospekterklärung enthält, die etwa am 30. Juni 2025 versandt wurde.
  • Die Pressemitteilung ist als Anlage 99.1 beigefügt; eine Inline-XBRL-Coverdatei ist als Anlage 104 verfügbar.
  • Die Einreichung betont, dass es sich nicht um ein Angebot zum Verkauf von Wertpapieren handelt und verweist Investoren darauf, kostenlose Kopien der Vollmachtsunterlagen über die SEC- oder Unternehmenswebsites zu beziehen.

Der Rest des Berichts besteht aus Haftungsausschlüssen zu zukunftsgerichteten Aussagen, die Risiken wie mögliche Rechtsstreitigkeiten, Integrationsprobleme, Einhaltung von Börsenzulassungsanforderungen und makroökonomische Gegenwinde darlegen. Es sind keine Finanzberichte oder Betriebsergebnisse enthalten.

false --12-31 0001981535 0001981535 2025-07-24 2025-07-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934

 

Date of Report (date of earliest event reported): July 24, 2025

 

SHARPLINK GAMING, INC.

(Exact name of registrant as specified in charter)

 

Delaware   001-41962   87-4752260

(State of

Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

333 Washington Avenue North, Suite 104

Minneapolis, Minnesota 55402

(Address of Principal Executive Offices) (Zip Code)

 

612-293-0619

(Registrant’s Telephone Number, Including Area Code)

 

 

(Former Name or Former Address, is Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 per share   SBET   The Nasdaq Stock Market, LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Directors; Compensatory Arrangements of Certain Officers.

 

At the Special Meeting (as defined below) of SharpLink Gaming, Inc. (the “Company”), stockholders approved an amendment and restatement of the Company’s 2023 Equity Incentive Plan (as amended and restated, the “Amended and Restated Equity Incentive Plan”) to increase the number of shares of common stock reserved for issuance thereunder by 8,000,000 shares to 8,034,166 shares.

 

The foregoing description of the Amended and Restated Equity Incentive Plan does not purport to be complete and is qualified in its entirety by reference to the full text of the Amended and Restated Equity Incentive Plan, a copy of which is attached as Exhibit 10.1 to this Current Report on Form 8-K (the “Current Report”) and incorporated herein by reference.

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On July 22, 2025, the Company filed a Second Certificate of Amendment (the “Certificate of Amendment”) to the Company’s Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company’s common stock, par value $0.0001 per share, from 100,000,000 to 500,000,000 and to make a corresponding change to the number of authorized shares of capital stock (the “Authorized Share Increase”). The Authorized Share Increase was approved by stockholders at the Special Meeting as described in Item 5.07 below and the Certificate of Amendment, including the Authorized Share Increase, became effective at 5:10 p.m. Eastern Time on July 24, 2025.

 

The foregoing description of the Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report and incorporated herein by reference.

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On July 24, 2025, the Company convened a special meeting of stockholders (the “Special Meeting”) virtually via live webcast. Only stockholders of record at the close of business on June 18, 2025, the record date for the Special Meeting, were entitled to vote at the Special Meeting. As of the record date, 62,125,336 shares of the Company’s common stock were outstanding and entitled to vote at the Special Meeting. Based on the estimated preliminary voting results present at the meeting or by proxy were holders of 35,076,578 shares of the Company’s common stock, which represented approximately 56% of the voting power of all shares of common stock as of the record date and constituted a quorum for the transaction of business at the Special Meeting.

 

The stockholders of the Company voted on the following two proposals at the Special Meeting:

 

  1. To adopt an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock of the Company; and
     
  2. To adopt the Amended and Restated Equity Incentive Plan.

 

The estimated preliminary results of each proposal were as follows:

 

Proposal No. 1 – Approval of an Amendment to the Company’s Amended and Restated Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock.

 

For   Against   Abstain   Broker Non-Votes
34,643,535   405,830   27,213  

 

Based on the votes set forth above, the stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock.

 

Proposal No. 2 – Approval of the Amended and Restated Equity Incentive Plan.

 

For   Against   Abstain   Broker Non-Votes
19,085,322   186,899   1,154,249   14,650,108

 

Based on the votes set forth above, the stockholders approved the Amended and Restated Equity Incentive Plan.

 

The Company plans to file an amendment to this Current Report with final numbers when available.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
Number
  Description
3.1   Second Certificate of Amendment to the Amended and Restated Certificate of Incorporation of SharpLink Gaming, Inc., effective as of July 24, 2025.
10.1   Amended and Restated Equity Incentive Plan.
104   Cover Page Interactive Data File (formatted as inline XBRL).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SHARPLINK GAMING, INC.
   
  By: /s/ Rob Phythian
  Name: Rob Phythian
  Title: Chief Executive Officer
Dated: July 25, 2025  

 

 

 

 

FAQ

When must SSY shareholders vote on the Regional Health merger?

Proxy votes are requested by 28 June 2025, 11:59 p.m. EDT.

What is the record date for SunLink’s merger vote?

Only holders of record as of 20 June 2025 are entitled to vote.

Where can investors access the joint proxy statement/prospectus for SSY?

Free copies are available on the SEC’s EDGAR system and on SunLink’s and Regional’s investor-relations webpages.

Which exhibit in the 8-K contains the related press release?

The press release is filed as Exhibit 99.1.

Does the 8-K include any new financial results for SunLink?

No. The filing contains no financial statements or earnings data; it is limited to merger-related voting information.
Sharplink Gaming Ltd

NASDAQ:SBET

SBET Rankings

SBET Latest News

SBET Latest SEC Filings

SBET Stock Data

2.58B
98.30M
8.6%
4.79%
0.98%
Gambling
Services-prepackaged Software
Link
United States
MINNEAPOLIS